StudySignal is MDM Worldwide's dedicated digital clinical trial recruitment platform — an end-to-end patient acquisition solution combining precision digital marketing, IRB-compliant creative development, advanced pre-screening, and real-time analytics.
Clinical trial enrollment delays are one of the most significant — and most costly — challenges facing drug developers today. Traditional recruitment methods: physician referrals, site-based outreach, print advertising, and patient registries — are no longer sufficient on their own in a world where patients are digitally native and increasingly proactive about their healthcare decisions.
StudySignal was built to solve this. We bring the full power of modern digital marketing to clinical trial patient recruitment — with the regulatory rigor, therapeutic area expertise, and data transparency that biotech and pharma sponsors require.
StudySignal manages the complete patient acquisition journey — from initial digital targeting through validated referral delivery to your clinical sites. Our integrated platform eliminates gaps, ensuring seamless workflows and transparent reporting for all stakeholders.
A custom-built, study-specific recruitment website serving as the central conversion engine — optimized for patient experience, mobile-ready, multi-language capable, and integrated with geographic site matching and automated referral processing.
Condition-specific targeting across Google Search & Display, Meta platforms (Facebook/Instagram), Reddit, TikTok for younger demographics, and specialty patient forums — deploying behavioral targeting, geographic precision, and lookalike audience development.
Therapeutic area-specific messaging and multi-format ad creative — search, display, video, and social — developed with regulatory compliance built in and continuous A/B testing to maximize engagement and conversion.
Multi-stage pre-qualification processes that assess eligibility against study-specific protocol criteria — reducing site burden, improving referral quality, and ensuring that the patients who reach your sites are genuinely qualified candidates.
A real-time recruitment dashboard with multi-level access for sponsors, sites, and management — providing live patient acquisition tracking, automated site distribution, comprehensive audit trails, and predictive analytics for timeline forecasting.
Full-transparency reporting on patient acquisition cost, channel performance, conversion rates, referral quality, site satisfaction, and budget utilization — delivering the ROI visibility that sponsors and CROs require.
What separates StudySignal from generic patient recruitment agencies is our foundation: MDM Worldwide has spent years embedded in the clinical-stage biotech world — writing about Phase 1/2/3 trials, communicating data readouts to investors, and understanding FDA communications guidelines.
Deep experience with oncology, rare disease, CNS, cardiovascular, and other complex therapeutic areas — enabling messaging that resonates with specific patient populations and their caregivers.
All creative assets and campaign materials are developed with IRB submission in mind. We coordinate the approval process and ensure every patient-facing element meets regulatory standards before launch.
We work as an extension of your clinical operations team — collaborating with sites, aligning with your CRO, and adapting continuously to study performance and evolving enrollment needs.
Our proven implementation process takes campaigns from kickoff to first referral delivery in approximately 60–90 days, including website development, creative production, and IRB approval coordination.
Custom recruitment website development, IRB-compliant creative asset production, targeting strategy development, keyword and demographic planning, IRB submission and approval coordination.
Multi-channel campaign launch, A/B ad testing, algorithm learning period, targeting optimization based on initial performance data, quality validation processes.
Full-scale patient acquisition operations, continuous performance optimization, comprehensive performance reporting, and validated referral delivery to clinical sites.
Budget allocation and Phase 2 planning are determined collaboratively based on Phase 1 performance data and evolving enrollment needs.
StudySignal operates as a collaborative partner — not a point solution. We coordinate directly with your clinical sites, align with your CRO workflows, and maintain transparent communication with all stakeholders throughout the campaign.
Whether you're launching a new study or struggling to hit enrollment targets on an existing trial, StudySignal can build a tailored digital recruitment program designed for your patient population, your sites, and your timeline.
StudySignal is a service of MDM Worldwide Solutions, Inc. · Email us at info@mdmworldwide.com with "StudySignal" in the subject line.